For a limited time register for the Evaluating Biopharma event for free using code "evaluate4" buff.ly/36OX7yG

For a limited time register for the Evaluating Biopharma event for free using code "evaluate4" buff.ly/36OX7yG

Once upon a time, a small biotech company found itself in a race with a competitor to bring an AIDS drug to clinical trial. Parrish Galliher helped this company get its drug into the clinic before its competition. buff.ly/37lK4Vj #biotech #lifescience #biopharma

For a limited time register for the Evaluating Biopharma event for free using code "evaluate4" buff.ly/36OX7yG

Evaluating Biopharma buff.ly/3ISsC8v brings together top industry experts to share, evaluate and discuss critical topics to help biopharma and bioprocessing leaders advance life sciences. #lifesciences #bioprocessing #biomanufacturing

In February, Adverum Biotechnology's Avril Vermunt discussed striking the balance between ROI and P&L when implementing new technologies. Download her case study for free at buff.ly/3NZHuF2 #biopharma #bioprocess #lifesciences

Evaluating Biopharma makes it easy for #bioprocessing, #biopharma, and #lifescience professionals to stay on top of the challenges and opportunities in the industry. Just look at the titles of these events. You'll want to attend! buff.ly/3HMMnhU

Plan to attend the Continuous Bioprocessing event on June 16. buff.ly/37e1Auu Use "evaluate4" to save 100% off registration before May 1. Next-generation roundtables for biopharma industry experts and decision-makers. buff.ly/3r2XiND #biopharma #bioprocessing

Evaluating Biopharma held three events and 15 speakers discussed shift to biologics, evolution of technology in bioprocessing, and strategies for operational efficiencies. All 15 presentations are available for free buff.ly/3j55mc7 #biopharma #lifescience #bioprocessing

Evaluating Biopharma makes it easy for #bioprocessing, #biopharma, and #lifescience professionals to stay on top of the challenges and opportunities in the industry. Just look at the titles of these events. You'll want to attend! buff.ly/3HMMnhU

Plan to attend the Continuous Bioprocessing event on June 16. buff.ly/37e1Auu Use "evaluate4" to save 100% off registration before May 1. Next-generation roundtables for biopharma industry experts and decision-makers. buff.ly/3r2XiND #biopharma #bioprocessing

Josefine Persson discusses how Genentech reduced product sampling volumes by 50+%reduced direct and indirect costs, improved COGS, and reduced environmental factors. Read the case study or watch the video of this Evaluating Biopharma presentation for free buff.ly/3HMMnhU

According to Bioplan Associates, industry leaders point to continuous processing as the most needed bioprocessing innovation. Join the June 16th virtual event to understand "Continuous Bioprocessing: Justifying your Company's Investment." buff.ly/36OX7yG #bioprocessing

Evaluating Biopharma is thrilled to confirm John Bonham-Carter as moderator for June 16 "Continuous Bioprocessing" virtual conference and networking event. Register by May 1 with code <evaluate4> to get a 100% discount. buff.ly/36OX7yG #bioprocess #biopharma #lifescieces

Parrish Galliher discusses he transform a severely inefficient manufacturing process for a promising drug in P3 into an efficient, safe, and licensable product. buff.ly/3xRsvHB

conta.cc/3uMRfPd

Confident your material supply chain is secure? Virtually join Evaluating Biopharma on Oct 6 for Supply Chain Challenges – Team Approach to Managing Risk: evaluatingbiopharma.com/supply-chain-c… #ebp #bioprocessing #biopharma

Please Join CHI's Evaluating Biopharma Supply Chain Challenges online education and networking event on October 6. Register here (use end-user option): register.healthtech.com/reg/scm #ebp #biopharma

Final weeks to register and improve your biopharmaceutical process intensification! View full agenda here: lnkd.in/emxjxF7T lnkd.in/eegnhneu

Moderator Ben Locwin (Black Diamond Networks) talks with Dave Backer (formerly OxfordBiomedica) about the crucial decision to “build or buy” when navigating supply chain issues in the CGT market, all in the latest Cambridge Healthtech Institute Evaluating Biopharma podcast episode.